Home > BIGG > Search result

    Results: 1

    Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline

    Kawano-Dourado, Leticia; Kristianslund, Eirik Klami; Zeraatkar, Dena; Jani, Meghna; Makharia, Govind; Hazlewood, Glen; Smith, Catherine; Jess, Tine; Stabell, Camilla; Schatten, Arne; Owen, Andrew; Gehin, Johanna; Katsidzira, Leolin; Weinberg, David; Bauer-Ventura, Iazsmin; Tugwell, Peter; Moayyedi, Paul; Cecchi, Ana Veronica Wolff; Shimabuco, Andrea; Seterelv, Siri; Gyatt, Gordon; Agoritsas, Thomas; Vandvik, Per Olav.
    BMJ; 28 (387), 2024
    Clinical question: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as compared with standard care? Context and c...
    Inflammatory Bowel Diseases/drug therapy, Arthritis, Rheumatoid/drug therapy, Psoriasis/drug therapy, Biological Products/therapeutic use
    Fulltext